GSK1562902A

GSK1562902A is an inactivated, split-virion H5N1 pandemic influenza vaccine developed by GSK. It is designed to provide active immunization against the H5N1 subtype of the influenza A virus, which is recognized for its significant pandemic potential. The vaccine utilizes GSK's proprietary AS03 adjuvant system, an oil-in-water emulsion containing alpha-tocopherol and squalene, which enhances the immune response and allows for dose-sparing. Clinical development has focused on evaluating the vaccine's safety, immunogenicity, and lot-to-lot consistency, particularly using the A/Indonesia/05/2005 strain, in healthy adult populations.

Brand names

Q-PanAdjupan

Other names

H5N1 pandemic influenza vaccineH-5N1 pandemic influenza vaccineH 5N1 pandemic influenza vaccineGSK H5N1 vaccineH5N1 A/Indonesia/05/2005 vaccine